APA (7th ed.) Citation

AP, S., FV, M., AG, I., AO, I., GD, D., KV, S., . . . EN, I. (2023). Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients. International journal of molecular sciences, 24(3), . https://doi.org/10.3390/ijms24031870

Chicago Style (17th ed.) Citation

AP, Sokolenko, et al. "Discrimination Between Complete Versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients." International Journal of Molecular Sciences 24, no. 3 (2023). https://doi.org/10.3390/ijms24031870.

MLA (9th ed.) Citation

AP, Sokolenko, et al. "Discrimination Between Complete Versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients." International Journal of Molecular Sciences, vol. 24, no. 3, 2023, https://doi.org/10.3390/ijms24031870.